Debra M. Hunter

1.8k total citations
31 papers, 1.3k citations indexed

About

Debra M. Hunter is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Debra M. Hunter has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Debra M. Hunter's work include Phagocytosis and Immune Regulation (15 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Mechanisms and Therapy (4 papers). Debra M. Hunter is often cited by papers focused on Phagocytosis and Immune Regulation (15 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Mechanisms and Therapy (4 papers). Debra M. Hunter collaborates with scholars based in United States, Germany and Finland. Debra M. Hunter's co-authors include H. Shelton Earp, Melissa Sandahl, Douglas K. Graham, Karen E. Strunk, Laura S. Caskey, Rebecca S. Muraoka-Cook, Deborah DeRyckere, Alisha Holtzhausen, Eric Ubil and Stephen V. Frye and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Debra M. Hunter

26 papers receiving 1.3k citations

Peers

Debra M. Hunter
Thomas Oellerich Germany
Stefan Florian Austria
Sébastien Letard France
David Wisniewski United States
Monther Al‐Alwan Saudi Arabia
Grant Wickman Canada
Erika von Euw United States
Oliver Dorigo United States
Cameron N. Johnstone Australia
Marianne Mollenauer United States
Thomas Oellerich Germany
Debra M. Hunter
Citations per year, relative to Debra M. Hunter Debra M. Hunter (= 1×) peers Thomas Oellerich

Countries citing papers authored by Debra M. Hunter

Since Specialization
Citations

This map shows the geographic impact of Debra M. Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra M. Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra M. Hunter more than expected).

Fields of papers citing papers by Debra M. Hunter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra M. Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra M. Hunter. The network helps show where Debra M. Hunter may publish in the future.

Co-authorship network of co-authors of Debra M. Hunter

This figure shows the co-authorship network connecting the top 25 collaborators of Debra M. Hunter. A scholar is included among the top collaborators of Debra M. Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra M. Hunter. Debra M. Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edwards, George M., et al.. (2024). MerTK Induces Dysfunctional Dendritic Cells by Metabolic Reprogramming. Cancer Immunology Research. 12(9). 1268–1285. 4 indexed citations
2.
Limaye, Aditya, et al.. (2023). CORPORATE GOVERNANCE AND CHOICE OF CAPITAL STRUCTURE. 23(2). 69–83.
3.
Holtzhausen, Alisha, Eric Ubil, Debra M. Hunter, et al.. (2019). TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti–PD-1 Therapy in Melanoma. Cancer Immunology Research. 7(10). 1672–1686. 98 indexed citations
4.
Asquith, Christopher R. M., Benedict‐Tilman Berger, James M. Bennett, et al.. (2019). SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK). Journal of Medicinal Chemistry. 62(5). 2830–2836. 45 indexed citations
5.
Ubil, Eric, et al.. (2018). Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response. Journal of Clinical Investigation. 128(6). 2356–2369. 135 indexed citations
6.
Zhang, Weihe, Deborah DeRyckere, Debra M. Hunter, et al.. (2014). UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor. Journal of Medicinal Chemistry. 57(16). 7031–7041. 118 indexed citations
7.
Liu, Jing, Weihe Zhang, Michael A. Stashko, et al.. (2013). UNC1062, a new and potent Mer inhibitor. European Journal of Medicinal Chemistry. 65. 83–93. 55 indexed citations
8.
Cook, Rebecca S., Kristen M. Jacobsen, Deborah DeRyckere, et al.. (2013). MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis. Journal of Clinical Investigation. 123(8). 3231–3242. 146 indexed citations
9.
Zhang, Weihe, Dehui� Zhang, Michael A. Stashko, et al.. (2013). Pseudo-Cyclization through Intramolecular Hydrogen Bond Enables Discovery of Pyridine Substituted Pyrimidines as New Mer Kinase Inhibitors. Journal of Medicinal Chemistry. 56(23). 9683–9692. 55 indexed citations
10.
Zhang, Weihe, Andrew L. McIver, Michael A. Stashko, et al.. (2013). Discovery of Mer Specific Tyrosine Kinase Inhibitors for the Treatment and Prevention of Thrombosis. Journal of Medicinal Chemistry. 56(23). 9693–9700. 40 indexed citations
11.
Liu, Jing, Chao Yang, Catherine Simpson, et al.. (2012). Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia. ACS Medicinal Chemistry Letters. 3(2). 129–134. 66 indexed citations
12.
Sandahl, Melissa, Debra M. Hunter, Karen E. Strunk, H. Shelton Earp, & Rebecca S. Cook. (2010). Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. BMC Developmental Biology. 10(1). 122–122. 66 indexed citations
13.
Muraoka-Cook, Rebecca S., Melissa Sandahl, Karen E. Strunk, et al.. (2009). ErbB4 Splice Variants Cyt1 and Cyt2 Differ by 16 Amino Acids and Exert Opposing Effects on the Mammary Epithelium In Vivo. Molecular and Cellular Biology. 29(18). 4935–4948. 63 indexed citations
14.
Hunter, Debra M.. (2008). What Happens when a Child Plays at the Sensory Table. Young children. 63(6). 77–79. 2 indexed citations
15.
Muraoka-Cook, Rebecca S., et al.. (2008). Prolactin and ErbB4/HER4 Signaling Interact via Janus Kinase 2 to Induce Mammary Epithelial Cell Gene Expression Differentiation. Molecular Endocrinology. 22(10). 2307–2321. 28 indexed citations
16.
Muraoka-Cook, Rebecca S., Debra M. Hunter, Melissa Sandahl, et al.. (2008). The E3 Ubiquitin Ligase WWP1 Selectively Targets HER4 and Its Proteolytically Derived Signaling Isoforms for Degradation. Molecular and Cellular Biology. 29(3). 892–906. 41 indexed citations
17.
Muraoka-Cook, Rebecca S., Laura S. Caskey, Melissa Sandahl, et al.. (2006). Heregulin-Dependent Delay in Mitotic Progression Requires HER4 and BRCA1. Molecular and Cellular Biology. 26(17). 6412–6424. 39 indexed citations
18.
Muraoka-Cook, Rebecca S., et al.. (2006). The Intracellular Domain of ErbB4 Induces Differentiation of Mammary Epithelial Cells. Molecular Biology of the Cell. 17(9). 4118–4129. 71 indexed citations
19.
Watson, Joanna M., Vita Golubovskaya, John S Morris, et al.. (2001). Inhibition of the Calcium-dependent Tyrosine Kinase (CADTK) Blocks Monocyte Spreading and Motility. Journal of Biological Chemistry. 276(5). 3536–3542. 50 indexed citations
20.
He, Yaqin, Xiong Li, Debra M. Hunter, et al.. (1998). Regulation of a Calcium-dependent Tyrosine Kinase in Vascular Smooth Muscle Cells by Angiotensin II and Platelet-derived Growth Factor. Journal of Biological Chemistry. 273(3). 1711–1718. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Oellerich Breakdown of academic impact, for papers by Stefan Florian Breakdown of academic impact, for papers by Sébastien Letard Breakdown of academic impact, for papers by David Wisniewski Breakdown of academic impact, for papers by Monther Al‐Alwan Breakdown of academic impact, for papers by Grant Wickman Breakdown of academic impact, for papers by Erika von Euw Breakdown of academic impact, for papers by Oliver Dorigo Breakdown of academic impact, for papers by Cameron N. Johnstone Breakdown of academic impact, for papers by Marianne Mollenauer
Rankless by CCL
2026